Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label AME study of a single oral dose of 14C-labeled investigational CNS drug in healthy men
NL-OMON40688Active, not recruiting
- Sponsor
- Lundbeck
- Start
- Mar 2014
- Countries
- 1
01
Overview
Open-label, single-arm trial in central nervous system conditions (CNSD) and mental disorder, sponsored by Lundbeck. Primary endpoint: Absorption, metabolism, and excretion endpoints. Started Mar 2014; status: active, not recruiting.
02
Conditions
central nervous system conditions (CNSD)mental disorder
Beyond the preview
Go deeper on NL-OMON40688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40688.